PLC mentioned it needs to considerably increase its footprint in well being, magnificence and hygiene, and plans to unload slower-growing components of its ice cream-to-soap shopper manufacturers empire to fund main acquisitions.
The strategic replace Monday got here days after Unilever mentioned it had approached
PLC and
Pfizer Inc.
about buying their consumer-healthcare joint venture, GSK Shopper Healthcare. A profitable acquisition of the enterprise, which sells all the things from Aquafresh toothpaste to Advil painkillers, would vastly increase Unilever’s presence in classes reminiscent of oral care and nutritional vitamins.
Glaxo mentioned Saturday that Unilever had made three proposals late final 12 months, which it rejected on the premise that they undervalued the enterprise and its future prospects. The most recent proposal, obtained on Dec. 20, valued the enterprise at £50 billion—equal to about $68.4 billion—and was made up of £41.7 billion in money and £8.3 billion in shares, it mentioned.
The surprising method for the enterprise, which Glaxo has been making ready to spin off later this 12 months, was extensively questioned by analysts, with shares in Unilever falling greater than 6% in early buying and selling Monday.
In its announcement Monday, Unilever defended the rationale for such a deal, saying well being, magnificence and hygiene provide larger charges of development due to the potential for innovation. The corporate additionally mentioned it may gain advantage from its current footprint in such classes in rising markets like China and India.
Unilever mentioned it had determined that large acquisitions to meet its strategic ambitions may very well be accompanied by the sale of lower-growth manufacturers and companies. For a lot of analysts, that remark affords the clearest intention but of the corporate’s plans to additional de-emphasize meals.
Though Unilever has offered meals since its inception, with the corporate’s roots in butter and margarine relationship again to the late 1800s, its meals arm has grown extra slowly than different companies like magnificence and private care. Unilever for years has confronted calls to spin off or promote the division, which homes manufacturers together with Ben & Jerry’s ice cream and Hellmann’s mayonnaise.
Different main shopper merchandise corporations reminiscent of
Procter & Gamble Co.
, Reckitt Benckiser Group PLC and
are primarily targeted on companies like private care, dwelling care and shopper well being, whereas others like
Nestlé SA
have publicity to classes seen as extra promising, reminiscent of espresso and pet meals.
Unilever lately has offered off large chunks of its meals enterprise, in 2018 selling its spreads unit for about $8 billion and in November hanging a roughly $5 billion deal to sell the bulk of its tea business.
Nonetheless, analysts roundly criticized the method for Glaxo’s consumer-healthcare enterprise.
“We predict it is a very unhealthy deal for Unilever shareholders,” mentioned Bernstein analyst Bruno Monteyne, including that he thinks Unilever—already struggling to drive development in its current enterprise—would wrestle additional to develop gross sales of the GSK shopper well being enterprise, which was rising slowly earlier than the pandemic.
Jefferies analyst Martin Deboo mentioned that whereas the advantages of mixing the nutritional vitamins and oral-care companies—which make up 45% of the Glaxo shopper well being enterprise—are clear, he questioned whether or not Unilever could be a superb proprietor of the over-the-counter enterprise. “Preliminary suggestions on the deal from traders over the weekend has been nearly uniformly detrimental,” he mentioned.
RBC analyst
James Edwardes Jones
famous that a lot of GSK’s consumer-health portfolio includes scientific or medical merchandise which are strictly regulated, creating hurdles to Unilever’s ambitions of rolling these out in new markets the way in which it’s used to doing with extra loosely regulated shopper manufacturers.
One other downside for Unilever is that its shares have fallen in latest months and funding an enormous deal such because the one it’s proposing would require it to tackle debt, analysts mentioned. Firms like P&G, Nestlé and Reckitt are seen by some analysts as extra possible consumers of the consumer-health enterprise and Unilever’s disclosure may spur comparable bulletins from others, they added.
Unilever on Monday additionally mentioned that later this month it might announce a “main initiative” aimed toward enhancing efficiency, including that the approaching adjustments would permit it to be extra agile, enhance its focus and strengthen accountability.
Write to Saabira Chaudhuri at saabira.chaudhuri+1@wsj.com
Copyright ©2022 Dow Jones & Firm, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
